MSF Challenges Gilead ’s Hepatitis C Patent Application in China

Press releaseMSF Challenges Gilead ’s Hepatitis C Patent Application in ChinaDecember 18, 2017The international medical humanitarian organization Doctors Without Borders/M édecins Sans Frontières (MSF) has filed a patent challenge in China to block Gilead’s patent application for the combination of two key oral hepatitis C medicines, sofosbuvir and velpatasvir.

http://feedproxy.google.com/~r/DoctorsWithoutBordersPR/~3/PUK5tuex8M4/msf-challe...

Source: MSF News - December 18, 2017 Category: International Medicine & Public Health Authors: Brienne Prusak Source Type: news

More News: China Health | Hepatitis | Hepatitis C | International Medicine & Public Health